The health economics of asthma and rhinitis. I. Assessing the economic impact

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 1, 2001, Pages 3-8

  Weiss, Kevin B ^a,b   Sullivan, Sean D ^a,b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cost of illness; Cost benefit; Cost effectiveness; Health economic evaluation

Indexed keywords

ASTHMA; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; PRIORITY JOURNAL; REVIEW; RHINITIS;

EID: 0035141851     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.112262     Document Type: Article

References (50)

1. Users' guides to the medical literature: XIII. How to use an article on economic analysis of clinical practice
2. Surveillance for asthma - United States, 1960-1995
3. A cost of illness study of allergic rhinitis in the United States
4. Looking into the crystal ball: Can we estimate the lifetime costs of rheumatoid arthritis?
5. Theoretical foundations of cost-effectiveness analysis
6. Foundations of cost-effectiveness analysis for health and medical practices
7. Measures for use in asthma clinical research. Overview of the NIH workshop
8. National Asthma Education and Prevention Program working group report on the cost-effectiveness of asthma care
9. Cost-effectiveness analysis as a guide to resource allocation in health: Roles and limitations
10. Identifying and valuing outcomes
11. An economic evaluation of asthma in the United States
12. A national estimate of the economic costs of asthma
13. Trends in the costs of illness for asthma in the United States, 1985-1994
14. The costs of asthma in New South Wales
15. On the social costs of asthma
16. Direct and indirect costs of asthma in Canada, 1990
17. Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands
18. The economic burden of asthma: Direct and indirect costs in Switzerland
19. The economic costs of asthma in Singapore
20. Un estudio economico sobre asthma en Mexico
21. Socio-economic burden of childhood asthma
22. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991
23. Direct and indirect costs associated with the management of childhood asthma
24. The cost of childhood asthma to Australian Families
25. The patient level cost of asthma in adults in south central Ontario. The Pharmacy Medication Monitoring Program and Advisory Board
26. Is asthma treatment affordable in developing countries?
27. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries
28. Health care costs associated with acute asthma: A prospective analysis
29. Cost of asthma illnesses: Emergency department visits without admission
30. The cost of asthma in the emergency department and hospital
31. Asthma: An analysis of high-cost patients
32. Cost of asthma therapy in relation to severity: An empirical study
33. Costs of asthma according to the degree of severity
34. Risk factors and costs associated with an asthma attack
35. Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists
36. Use of health services by African-American children with asthma on Medicaid
37. The economic burden of asthma in US children: Estimates from the national medical expenditure survey
38. Measuring productivity loss days in asthma patients. The Pharmacy Medication Monitoring Program and Advisory Board
39. Cost of hay fever in the United States in 1990
40. Utilization and cost of immunotherapy for allergic asthma and rhinitis
41. Allergic rhinitis in Rochester, Minnesota residents with asthma: Frequency and impact on health care charges
42. Cognitive, social, and economic costs of allergic rhinitis
43. Medical expenditures for the treatment of allergic rhinoconjunctivitis in the United States in 1996 including the contributions of related airway illness
44. The cost of productivity losses associated with allergic rhinitis
45. Cost implication of allergic rhinitis